Edge Capital Group LLC Buys 185 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Edge Capital Group LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,700 shares of the healthcare conglomerate’s stock after buying an additional 185 shares during the quarter. Edge Capital Group LLC’s holdings in UnitedHealth Group were worth $1,366,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UNH. M&T Bank Corp increased its stake in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after purchasing an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC increased its stake in shares of UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. increased its stake in shares of UnitedHealth Group by 1,275.3% during the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $21,165,000. Finally, Signal Advisors Wealth LLC grew its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after buying an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Down 7.3 %

UNH opened at $465.58 on Monday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $428.46 billion, a PE ratio of 30.04, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. The company has a fifty day moving average of $519.27 and a 200-day moving average of $560.44. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on UNH shares. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Thursday, January 23rd. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Stephens increased their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.33% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.